VITL — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-11-03

• At times, significant HPAI-related disruptions in the supply of conventional eggs have resulted in increased demand for premium egg products such as ours, which occasionally resulted in shortages of our eggs on shelves at our retail customers. While we have not experienced material disruptions to ou…

• Additionally, agricultural diseases such as HPAI or EDS have resulted and could in the future result in supply shortages and price increases across the egg market, including shortages of eggs on shelves at our retail customers. We are confident in the measures we have taken to reduce the risk of HPA…

• Comparison of the 13-Week Periods Ended September 27, 2026 and September 28, 2025

• The decrease in selling, general and administrative expenses of $6.3 million, or 14%, was primarily driven by:

• a decrease of $4.2 million in employee-related costs, including stock-based compensation, driven by lower compensation expenses and decreased expenses related to employee travel;

Text removed vs the prior filing · source: 10-Q · 2026-08-06

• At times since 2024, HPAI-related disruptions in the supply of conventional eggs resulted in increased demand for premium egg products such as ours, which occasionally resulted in shortages of these eggs on shelves at our retail customers. While we have not experienced material disruptions to our eg…

• The increase in selling, general and administrative expenses of $1.4 million, or 4%, was primarily driven by expenses to support the expansion of our business and continued growth, including:

• an increase of $2.7 million in professional services, driven by consulting fees associated with our feed cost savings program;

• a decrease of $2.1 million in employee-related costs, including stock-based compensation, driven by a change in estimate based on revised expectations of the attainment levels for performance metrics of certain PSUs; and

• a decrease of $0.4 million in other selling, general, and administrative expenses.

Text added vs the prior filing · source: 10-Q · 2026-11-03

• We are subject to interest rate risk in connection with our Silver Point Term Loan. See the section titled “—Liquidity and Capital Resources—Credit Facilities” above for additional details related to our credit facilities. Borrowings under the Silver Point Term Loan may from time to time require pay…

• As of September 27, 2026, a hypothetical 1% (100 basis points) increase in the applicable rate over any applicable floor would result in an annualized increase of approximately $1.25 million of incremental expense related to our variable-rate debt borrowings under the Silver Point Term Loan.

• We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure during the 13-week and 39-week periods ended September 27, 2026.

• Other than the interest rate risk discussed above, there have been no material changes in our exposure to market risk during the 13-week and 39-week periods ended September 27, 2026 from the information provided in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our…

Text removed vs the prior filing · source: 10-Q · 2026-08-06

• There have been no material changes in our exposure to market risk during the 13-week and 26-week periods ended June 28, 2026 from the information provided in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our latest Annual Report.

Text added vs the prior filing · source: 10-Q · 2026-11-03

• We have experienced significant growth from inception to date, and we anticipate further growth. Our historical growth since inception may not be indicative of our future growth. Our net revenue increased from $471.9 million in fiscal 2023 to $606.3 million in fiscal 2024 to $759.4 million in fiscal…

• We have experienced net losses in recent fiscal periods, including a net loss of $1.5 million in the 13-week period ended March 29, 2026, a net loss of $31.1 million in the 13-week period ended June 28, 2026, and a net loss of $6.5 million in the 13-week period ended September 27, 2026. In recent pe…

• The JPMorgan ABL Credit Facility provides for a $60.0 million revolving credit facility, and the Silver Point Term Loan provides for a $125.0 million term loan, which we have drawn in full. During the 13-week period ended September 27, 2026, we did not draw on the JPMorgan ABL Credit Facility, and o…

• If consumers do not perceive our products to be of high quality or safe, then the value of our brand would be diminished, and our business, results of operations and financial condition would be adversely affected. Any loss of confidence on the part of consumers in the quality and safety of our prod…

• From time to time, there may be changes in our senior leadership team or other key crew members resulting from the hiring or

Text removed vs the prior filing · source: 10-Q · 2026-08-06

• Our business has grown since inception, and we anticipate further growth. Most recently, our net revenue increased from $347.0 million in the 26-week period ended June 29, 2025 to $353.2 million in the 26-week period ended June 28, 2026; however, our net revenue decreased from $184.8 million in the …

• We have experienced net losses in recent fiscal periods, including a net loss of $1.5 million in the 13-week period ended March 29, 2026 and a net loss of $31.1 million in the 13-week period ended June 28, 2026. During the 13-week period ended June 28, 2026, our gross margin declined significantly, …

• The JPMorgan ABL Credit Facility provides for a $60.0 million revolving credit facility, and the Silver Point Term Loan provides for a $125.0 million term loan. We were previously party to the JPMorgan Credit Facility, which terminated concurrently with our entry into the JPMorgan ABL Credit Facilit…

• business.” Any factor adversely affecting sales of our shell eggs (including consumers’ election to purchase other brands or as a result of supply fluctuations) could have an adverse effect on our business, financial condition and results of operations.

• When our actual results differ materially from our prior guidance or from the expectations of securities analysts or investors, our reputation and relationships with customers and investors may be harmed and our stock price may decline. In recent periods, our results have fallen short of our publicl…

Text removed vs the prior filing · source: 10-Q · 2026-08-06

• Russell Diez-Canseco, Executive Chairperson, President and Chief Executive Officer

• * Contract, instructions, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

• ** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.